An additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25 were evaluable for efficacy SYS6002 (CRB-701) demonstrated 44% ORR and 78% DCR in mUC and 43% ORR ...
A state-of-the-art facility allowing Pfizer Inc. to significantly expand its global clinical manufacturing and speed critical therapies to patients has been awarded the 2020 Facility of the Year Award ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback